[Experience with te new antitubercular agents isoxyl, ethambutol, morphazinamid and rifomycin].
D046508:Culture Techniques; D003523:Cycloserine / Q000627:therapeutic use; D004977:Ethambutol / Q000627:therapeutic use*; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D009000:Monocytes; D010670:Phenylthiourea / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D011719:Pyrazines / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
D011719:Pyrazines; C100189:thiocarlide; D010670:Phenylthiourea; D004977:Ethambutol; D003523:Cycloserine; D007538:Isoniazid; D012293:Rifampin
Erfahrungen mit den neueren Tuberkuloseheilmitteln Isoxyl, Ethambutol, Morphazinamid und Rifamycin.